INMUNE BIO INC. Proceeds from Issuance of Warrants
INMUNE BIO INC. (INMB) reported Proceeds from Issuance of Warrants of $67.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfWarrants · last filed 2026-03-30
- INMUNE BIO INC. proceeds from issuance of warrants for fiscal 2025 was $67.00M.
| Period end | Proceeds from Issuance of Warrants | Proceeds from Issuance of Warrants 12 month |
|---|---|---|
| 2025-12-31 | $67.00M 10-K · filed 2026-03-30 | |
| 2024-04-30 | $4.50M 10-Q · filed 2024-10-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |